Skip to main content

Bardavon Health Innovations Acquires PeerWell to Become First Complete Digital Health Solution Focused on Worker Musculoskeletal Health

Together, Bardavon and PeerWell Pair In-Person Therapy, Virtual Coaching, and Self-Care for Injury Prevention and Recovery

OVERLAND PARK, KS, June 14, 2022 (GLOBE NEWSWIRE) — Bardavon Health Innovations has acquired PeerWell, Inc., a consumer-focused musculoskeletal (MSK) health application to create a truly hybrid treatment solution for workers across America. With this acquisition, the two companies will pair in-person physical therapy with virtual tools to support patients before, during, and after injury.

PeerWell’s technology augments the Bardavon bNOTES® clinical guidance system and Digital Health Platform to proactively optimize and orchestrate MSK care across a national network of over an estimated 21,000 physical and occupational therapy providers.

Together, the combined platform becomes the largest and highest performing quality MSK provider network in the United States with the following capabilities:

  • 21,000 physical and occupational therapists across all fifty states, with 90% U.S. population coverage
  • Digital and virtual whole person care pathways that complement in-person physical therapy for all common MSK disorders
  • Patented and clinically validated remote monitoring technology

“We focus on the worker and the unique clinical and professional needs of that population, understanding how the patients’ existing health, lifestyle, and job demands factor into their recovery,” said Matt Condon, Chief Executive Officer and founder of Bardavon Health Innovations. “Bringing in PeerWell’s leading digital engagement capabilities is the next evolutionary step.”

“A complete 360-degree MSK care experience has not existed until today,” noted Manish Shah, Chief Executive Officer and co-founder of PeerWell. “Each person is different, and each patient’s response to treatment is different. This pairing between what occurs in the clinic and what occurs at home has the chance to alter worker health on a totally different scale.”

As part of the cash and stock transaction, PeerWell investors will become Bardavon shareholders, including institutional investors xSeed Capital and OMERS Ventures.

“MSK is a significant area where we have still not seen clinical and digital care well integrated”, said PeerWell board member Dr. Jonathan Slotkin, Chief Medical Officer of Contigo Health and vice chair of neurosurgery at Geisinger. “Of the care journeys driving employer-sponsored healthcare spending, 34.2 percent is spent on MSK conditions—a greater amount than any other category including cancer, diabetes, and behavioral health.”

About Bardavon Health Innovations

Bardavon is an industry-leading provider of musculoskeletal health solutions in the physical therapy space focused on getting the workers of America back to work and life. Our technologies help our national network of 21,000 physical and occupational therapist providers optimize patient treatment while facilitating enhanced claims management for the payer. We put patients at the center of all we do as we strive to fundamentally change the healthcare marketplace. Learn more at www.bardavon.com.

About PeerWell

Founded in 2015, PeerWell is a musculoskeletal digital health platform that has helped thousands of patients. By activating the patient and coordinating their multi-specialty care, PeerWell reduces the cost of care and fragmentation, lowers risk, and improves health outcomes as well as recovery and return-to-work times. PeerWell helps people recover faster with devices they already own, safely from home. To learn more, visit www.peerwell.co.

CONTACT: Marny Burke
Bardavon Health Innovations
913-226-4647
mburke@bardavon.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.